Paul R. Fonteyne serves as Executive at AMAG PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Paul R. Fonteyne has executed 12 insider transactions totaling $350.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 1, 2024 involved receiving (via award) 3,341 shares valued at $0.
Paul R. Fonteyne currently holds 16,438 shares of AMAG PHARMACEUTICALS, INC. (AMAG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul R. Fonteyne has been a net buyer of AMAG stock. They have purchased $350.2K and sold $0 worth of shares.
Paul R. Fonteyne's most recent insider trade was on Jan 1, 2024, when they sold 3,341 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 13, 2022 | CVET | $0 | Disposition | 13,275 | $N/A | Discretionary |
| Jul 1, 2022 | CVET | $0 | Option Exercise | 8,275 | $N/A | Discretionary |
| May 6, 2022 | GLS | $0 | Award | 53,832 | $N/A | Discretionary |
| Jan 6, 2022 | AMLX | $75.0K | Purchase | 3,947 | $19.00 | Discretionary |
| Jan 1, 2022 | APLS | $0 | Award | 4,230 | $N/A | Discretionary |
| Aug 10, 2021 | CVET | $116.2K | Purchase | 5,000 | $23.24 | Discretionary |
| Nov 16, 2020 | AMAG | $0 | Disposition | 14,676 | $N/A | Discretionary |
| Jun 2, 2020 | AMAG | $0 | Award | 10,269 | $N/A | Discretionary |
| May 8, 2020 | APLS | $159.1K | Purchase | 5,000 | $31.81 | Discretionary |
| Oct 8, 2019 | AMAG | $0 | Award | 4,407 | $N/A | Discretionary |